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Prevalence, severity, and evolution of postsurgical 
anemia after gastrectomy, and clinicopathological 
factors affecting its recovery
Oh Jeong, Young Kyu Park, Seong Yeop Ryu
Division of Gastroenterologic Surgery, Department of Surgery, Chonnam National University Hwasun Hospital, Hwasun, Korea
Purpose: Postsurgical anemia is one of the common unpleasant postoperative sequels during the early postoperative period 
after gastrectomy, for which no standard care has been established. To facilitate proper management, we investigated the 
clinical features of postsurgical anemia and sought to identify the factors affecting its subsequent recovery. Methods: A retro-
spective review of 406 consecutive gastric cancer patients who underwent gastrectomy without systemic chemotherapy be-
tween August 2008 and September 2009. Clinical courses of postsurgical anemia were monitored at 3, 6, and 12 months 
post-surgery. Clinicopathological factors affecting recovery of postsurgical anemia were analyzed using a multivariate logis-
tic regression model. Results: The study subjects consisted of 265 males and 141 females (mean age, 61.8 years). After oper-
ation, 318 (78.3%) presented with postsurgical anemia, and 217 (66.7%) and 47 (11.6%) had mild or moderate anemia, re-
spectively, at the time of discharge. During the follow-up, 173 (54.4%) of the 318 with postsurgical anemia showed a sponta-
neous recovery at 3 months post-surgery, but no significant changes were observed in postsurgical anemia at 6 or 12 months 
post-surgery. Univariate and multivariate analysis revealed that old age (≥60 years), preoperative anemia, anemia severity 
(moderate anemia), and total gastrectomy were independent factors that adversely affect the spontaneous recovery of post-
surgical anemia after gastrectomy. Conclusion: Proper intervention may be required for postsurgical anemia that does not 
achieve a spontaneous recovery until postoperative 3 months. However, proper management, such as the use of iron or the 
best route for iron supplementation, needs to be evaluated in future clinical trials.
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INTRODUCTION
Despite its decreasing global incidence over the past 
few decades, gastric carcinoma remains one of the most 
common malignancies in many East Asian countries [1]. In 
Korea, gastric carcinoma is the most prevalent malignant 
neoplasm and continues to affect over 2,500 patients per 
year [2]. However, with widespread implementation of 
screening programs, early gastric cancer accounts for 
nearly 50% of all gastric cancers, and 5-year survival has 
reached up to 63 to 73% after curative resection [3-5]. 
Given advances in the treatment techniques and the early Oh Jeong, et al.
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diagnosis of gastric cancer, proper management of func-
tional and nutritional impairments after gastric cancer 
surgery has also become a primary treatment concern in 
gastric cancer [6].
Postsurgical anemia is frequently encountered during 
the early postoperative period after gastrectomy and may 
impair physical performance and postoperative recovery. 
However, no standard care for postsurgical anemia, such 
as, concerning the use of iron or the best route for iron sup-
plementation, has been established so far [7,8]. In the stud-
ies regarding orthopedic or cardiac surgery, oral or intra-
venous iron supplementation showed little efficacy for 
postsurgical anemia [9-12]. However, unlike patients un-
dergoing orthopedic or cardiac surgery, patients with gas-
trectomy inevitably suffer from poor iron absorption from 
the gastrointestinal tract, and thus, this may adversely af-
fect the physiologic recovery from postsurgical anemia 
[13]. Therefore, the use of iron supplementation for post-
surgical anemia needs to be further evaluated in the subset 
of patients undergoing gastrectomy. 
To facilitate proper management of postsurgical ane-
mia, a comprehensive understanding about its clinical fea-
tures is essential. Its prevalence, subsequent evolution, 
and the factors affecting the recovery should be taken into 
consideration when planning a treatment for postsurgical 
anemia. Therefore, we investigated clinical features of 
postsurgical anemia after gastrectomy, and sought to 
identify clinicopathological factors that affect its sub-
sequent recovery. 
METHODS
Patients
Between August 2008 and September 2009, 649 patients 
underwent curative surgery for gastric carcinoma at our 
institute. Of these patients, 198 patients that underwent 
preoperative or postoperative chemotherapy, 12 with 
combined resection of other organs, and 40 that experi-
enced disease recurrence during the follow-up were 
excluded. Finally, 406 patients that received gastrectomy 
alone for the treatment of gastric carcinoma and followed 
for at least one year after surgery were enrolled in the pres-
ent study. Patient data, such as, demographic character-
istics, pathologic results, operative details, postoperative 
morbidity and mortality, and hospital courses were pro-
spectively constructed using our electronic database re-
cording system. 
Postsurgical anemia was defined according to the 
World Health Organization definition based on hemoglo-
bin (Hgb) value (Hgb ＜  13 g/dL for males and ＜12 g/dL 
for females). The severity of anemia was also classified as 
mild (Hgb ≥ 10 g/dL), moderate (7 g/dL ≤ Hgb ＜ 10 
g/dL), or severe (Hgb ＜ 7 g/dL) based on postoperative 
Hgb concentration [14].
During the follow-up, all patients were monitored until 
12 months post-surgery, with regular blood test on 3, 6, 
and 12 months post-surgery. No specific treatment was 
given to patients with postsurgical anemia. Instead, addi-
tional laboratory test for iron deficiency, including serum 
iron and ferritin and total iron biding capacity, was carried 
out when patients showed microcytic or hypochromic 
anemia on regular blood test from postoperative 3 
months, and oral iron supplementation was indicated on-
ly for postsurgical anemia with an evidence of iron 
deficiency. Consequently, 11 patients received oral iron 
supplementation during the follow-up.
Operative procedures and perioperative care
Distal or total gastrectomy with regional lymph node 
dissection was performed in all patients. D2 lymph node 
dissection, as outlined by the Japanese Gastric Cancer 
Association, was the standard procedure used for ad-
vanced gastric cancer, and D1 plus beta lymph node dis-
section the standard procedure for early gastric cancer 
[15]. Laparoscopic surgery was indicated for patients with 
a preoperative diagnosis of cT1-2N0 gastric cancer. 
Billroth I reconstruction was the primary procedure used 
after distal gastrectomy, and Billroth II or Roux-en Y gas-
trojejunostomy when gastroduodenostomy was not fea-
sible because of concerns about anastomosis failure or the 
need for wide stomach resection. Roux-en Y esoph-
agojejunostomy without a pouch, was performed rou-
tinely after total gastrectomy.
Patients were perioperatively managed using a stand-
ardized clinical pathway protocol. For example, no pre-Postsurgical anemia after gastrectomy
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                   Characteristic Value
Age (yr), mean (SD) 61.8 (11.2)
Sex, n (%)
 Male 265 (65.3)
 Female 141 (34.7)
BMI (kg/m
2), mean (SD) 23.5 (3.2)
Underlying comorbidity, n (%) 155 (38.2)
 Diabetes mellitus 118 (29.1)
 Hypertension   57 (14.0)
 Chronic obstructive pulmonary disease   22 (5.4)
 Liver cirrhosis     7 (1.7)
 Others     7 (1.7)
Resection type, n (%)
 Distal gastrectomy 342 (84.2)
 Total gastrectomy   64 (15.8)
Operative approach, n (%)
 Open surgery 184 (45.3)
 Laparoscopic surgery 222 (54.7)
Lymph node dissection, n (%)
 D1 plus beta 239 (58.9)
 D2 167 (41.1)
TNM stage
a), n (%)
 IA 326 (80.3)
 IB   80 (19.7)
SD, standard deviation; BMI, body mass index; TNM, tumor- 
node-metastasis.
a)The seventh edition of Union for International Cancer Control/ 
American Joint Committee on Cancer TNM classification.
Table 1. Patients’clinicopathological characteristics (n = 406) operative bowel preparation or nasogastric tube was used. 
Patients were administered an oral diet from post-
operative day 1, and intravenous fluid was restricted to 20 
to 25 mL/kg/day during the first three postoperative days. 
Prophylactic antibiotics were administered before skin in-
cision and continued until 12 hours after surgery. Labora-
tory tests, such as, complete blood cell counts and blood 
chemistry, were regularly performed on postoperative 
days 1, 3, and 5. Transfusion was indicated for anemia with 
Hgb concentration of ＜6 g/dL or active postoperative 
bleeding [16]. Hospital discharge was targeted for post-
operative day 8, and objective discharge criteria were used 
to make decisions, that is, no sign of postoperative compli-
cations, the ability to ambulate without assistance, toler-
able pain on oral analgesia, able to consume more than 70 
per cent of meals, and a willingness to go home.
Statistical analysis
Continuous data were converted into means (standard 
deviations [SDs]) and analyzed using the Student’s t-test. 
The chi-square test was used to analyze categorical data. 
When analyzing risk factors, continuous data were dicho-
tomized into categorical data, which enables the chi- 
square test and logistic regression analysis to be used for 
univariate and multivariate analysis, respectively. All stat-
istical analyses were performed using SPSS ver. 12.0 (SPSS 
Inc., Chicago, IL, USA). P-values of ＜  0.05 were regarded 
statistically significant. 
RESULTS
Patient characteristics
The demographic and treatment characteristics of the 
406 patients are summarized in Table 1. The study subjects 
consisted of 265 males and 141 females of mean age (SD) 
61.8 (11.2) years. One hundred and fifty five (38.2%) had 
underlying medical comorbidities at the time of operation. 
Distal gastrectomy was performed in 342 (84.2%), and to-
tal gastrectomy in 64 (15.8%) patients. Laparoscopic sur-
gery was performed in 222 (54.75%) patients. Based on fi-
nal pathologic examinations and the seventh edition of the 
Union for International Cancer Control tumor-node- 
metastasis classification, there were 326 stage IA and 80 
stage IB patients. 
Prevalence and severity of postsurgical anemia
Postoperatively, 318 (78.3%) patients presented with 
postsurgical anemia, and these included 30 (7.4%) patients 
with a postoperative bleeding complication. Mean esti-
mated intraoperative blood loss (mL) was 175 ± 39, and 
mean change in Hgb concentration immediately after sur-
gery was 2.3 ± 1.4 g/dL. Forty one (10.1%) patients received 
a blood transfusion postoperatively. Because we sought to 
monitor the postoperative recovery of serum Hgb level 
from the baseline level at the time of discharge, we decided 
to include the patients receiving perioperative blood 
transfusion based on their last blood test results. Finally, at 
the time of discharge from hospital (based on the last 
blood test before discharge), 271 (66.7%) patients had mild 
and 47 (11.6%) had moderate postsurgical anemia, but no Oh Jeong, et al.
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               Variable
Univariate Multivariate
Patients 
(n = 341)
Anemia, n (%) 
(n = 253)
P-value OR 95% CI P-value
Age (yr) 0.004 0.022
  ＜60 129  85 (65.9) 1 (ref)
  ≥60 212 168 (79.2) 1.87 1.10-3.16
Sex 0.023 0.028
  Male 229 162 (70.7) 1 (ref)
  Female 112  91 (81.3) 1.89   1.0-3.40
BMI (kg/m
2) 0.008 0.011 
  ≥23 234 162 (69.2) 1 (ref)
  ＜23 107  91 (85.0) 2.26 1.21-4.24
Comorbidity 0.552
  Absent 251 199 (79.3)
  Present 155 119 (76.8)
Resection type ＜0.001 0.002
  Distal gastrectomy 287 202 (79.8) 1 (ref)
  Total gastrectomy   54  51 (94.4) 6.61 1.95-22.41
Reconstruction ＜0.001
  Billroth I 253 180 (71.1)
  Billroth II   29  18 (62.1)
  RYGJ     5    4 (80.0)
  RYEJ   54  51 (94.4)
Operative approach 0.034 0.804
  Laparoscopy 190 133 (70.0) 1 (ref)
  Open 151 120 (79.5) 1.09 0.58-2.06
Lymph node dissection 0.014 0.204
  D1 plus beta 204 142 (69.6) 1 (ref)
  D2 137 111 (81.0) 1.53 0.80-2.95
Operating time, min 0.639
  ＜180 162 123 (75.9)
  ≥180 179 130 (72.6)
BMI, body mass index; OR, odds ration; CI, confidence interval; RYEJ, Roux-en Y esophagojejunostomy; RYGJ, Roux-en Y 
gastrojejunostomy.
Table 2. Univariate and multivariate analysis of risk factors of developing postsurgical anemia in patients without preoperative anemia
patient had severe anemia.
Risk factors for developing postsurgical anemia
Of the 341 patients without preoperative anemia, 253 
(74.2%) developed postsurgical anemia. Table 2 summa-
rizes the risk factors of developing postsurgical anemia in 
patients without preoperative anemia. Univariate analysis 
showed that old age, female sex, lower body mass index 
(BMI), open surgery, D2 lymph node dissection, and total 
gastrectomy were significantly associated with the devel-
opment of postsurgical anemia after gastrectomy. As for 
reconstruction types, Roux-en Y esophagojejunostomy 
was significantly related to the development of post-
surgical anemia, but patients with distal gastrectomy 
showed no significant difference of postsurgical anemia 
according to the reconstruction techniques (P = 0.589, 
Fisher’s exact test). Therefore, reconstruction type was ex-
cluded in the multivariate analysis. Multivariate analysis 
revealed that old age (≥60 years; odds ratio [OR], 1.87; 
95% confidence interval [CI], 1.10 to 3.16), a female sex 
(OR, 1.89; 95% CI, 1.05 to 3.40), lower BMI (＜  23; OR, 2.26; 
95% CI, 1.21 to 4.24), and total gastrectomy (OR, 6.61; 95% 
CI, 1.95 to 22.41) were independent risk factors of develop-
ing postsurgical anemia after gastrectomy. Postsurgical anemia after gastrectomy
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Severity of 
postsurgical anemia
Anemia, n (%)
Postop 3 mo Postop 6 mo Postop 12 mo
Absent Present Absent Present Absent Present
None (n = 88)   79 (89.8)     9 (10.2)   81 (92.0)   7 (8.0)   82 (93.2)   6 (6.8)
Mild anemia (n = 271) 161 (59.4) 110 (40.6) 172 (63.5)  99 (36.5) 169 (62.4) 102 (37.6)
Moderate anemia (n = 47)   12 (25.5)   35 (74.5)  17 (36.2)  30 (63.8)   14 (29.8)  33 (70.2)
Total  (n = 406) 252 (62.1) 154 (37.9) 270 (66.5) 136 (33.5) 265 (65.3) 141 (34.7)
Table 3. Evolution of postsurgical anemia during follow-up
          Variable
Patients 
(n = 307)
Anemia, n (%) 
(n = 128)
P-value
Age (yr) 0.005
 ＜60 102   31 (30.4)
 ≥60 205   97 (47.3)
Sex 0.668
 Male 189   77 (40.7)
 Female 118   51 (43.2)
BMI (kg/m
2)0 . 0 6 5
 ≥23 159   58 (36.5)
 ＜23 148   70 (47.3)
Comorbidity 0.931
 Absent 191   80 (41.9)
 Present 116   48 (41.4)
Preoperative anemia ＜0.001
 Absent 248   86 (34.7)
 Present  59   42 (71.2)
Severity of anemia ＜0.001
 Mild 245   89 (36.3)
 Moderate  62    39 (62.9)
Reconstruction ＜0.001
 Billroth I 217   76 (35.0)
 Billroth II  25     9 (36.0)
 RYGJ    5     4 (80.0)
 RYEJ  60   39 (65.0)
Resection type ＜0.001
 Distal gastrectomy 247   89 (36.0)
 Total gastrectomy  60   39 (65.0)
Operative approach 0.250
 Laparoscopy 163   63 (38.7)
 Open 144   65 (45.1)
Lymph node dissection 0.195
 D1 plus beta 174   67 (38.5)
 D2 133   61 (45.9)
Postop morbidity 0.803
 Absent 262 110 (42.0)
 Present  45   18 (40.0)
BMI, body mass index; RYGJ, Roux-en Y gastrojejunostomy; RYEJ, 
Roux-en Y esophagojejunostomy.
Table 4. Univariate analysis of predictors of persistent postsurgical 
anemia until 12 months after surgery
Evolution of postsurgical anemia during follow-up
Table 3 present postoperative courses of postsurgical 
anemia up to 12 months post-surgery. Of the 318 patients 
with postsurgical anemia, 173 (54.4%) achieved a sponta-
neous recovery at 3 months post-surgery without specific 
treatment. Patients with mild postsurgical anemia showed 
significantly better spontaneous recovery by 3 months 
post-surgery than those with moderate postsurgical ane-
mia (59.4% vs. 25.5%; P ＜  0.001). However, no significant 
change in the recovery of postsurgical anemia was ob-
served at 6 or 12 months postoperatively for both patient 
groups with mild and moderate postsurgical anemia. 
During the follow-up, only 11 (3.5%) of 318 patients with 
postsurgical anemia showed microcytic or hypochromic 
anemia with iron deficiency based on the blood test from 
the postoperative 3 months, and received oral iron 
supplementation.
Interestingly, of the 88 patients that did not develop 
postsurgical anemia after operation, only 9 (10.2%) newly 
developed anemia by postoperative 3 months, and 6 of 
them presented with anemia until 12 months post-surgery.
Factors affecting the recovery of postsurgical ane-
mia
As we mentioned earlier, 11 postsurgical patients with 
iron deficiency received oral iron supplementation during 
the follow-up, and thus these patients were excluded from 
the analysis of factors affecting the recovery of post-
surgical anemia to exclude the effects of iron treatment. 
Table 4 presents a summary of our analysis of predictors of 
persistent postsurgical anemia by 12 months postopera-
tively. According to univariate analysis, old age, the pres-
ence of preoperative anemia, severity of anemia (mode-Oh Jeong, et al.
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Odds 
ratio
95% confidence 
interval
P-value
Age (≥60 yr) 2.47 1.40-4.34    0.002
Preoperative anemia 4.87 2.48-7.96 ＜0.001
Severity of anemia 
  (moderate)
2.19 1.03-4.63    0.041
Resection type
  (total gastrectomy)
4.14 2.15-7.97 ＜0.001
Table 5. Multivariate analysis of factors affecting the recovery of 
postsurgical anemia
rate), reconstruction type, and total gastrectomy were sig-
nificantly associated with persistent postsurgical anemia 
by 12 months. In the subgroup analysis of patients with 
distal gastrectomy, there was no significant difference in 
the recovery of postsurgical anemia between different 
types of reconstruction procedure (P = 0.140, fisher’s exact 
test). Finally, multivariate analysis revealed that old age 
(≥60 years; OR, 2.47; 95% CI, 1.40 to 4.34), preoperative 
anemia (OR, 4.87; 95% CI, 2.48 to 7.96), moderate post-
surgical anemia (OR, 2.19; 95% CI, 1.03 to 4.63), and total 
gastrectomy (OR, 4.14; 95% CI, 2.15 to 7.97) were in-
dependent risk factors that adversely affect the sponta-
neous recovery of postsurgical anemia (Table 5).
DISCUSSION
Postsurgical anemia is common postoperative sequel 
during the early postoperative period after gastrectomy, 
and probably adversely affects physical performance and 
recovery. However, no clear consensus has been reached 
regarding the treatment of postsurgical anemia after gas-
trectomy, such as, whether to use iron or to determine the 
optimum route of iron supplementation [17]. The proper 
management of postsurgical anemia after gastrectomy 
may be best approached from a comprehensive under-
standing of its clinical features, but little is known about 
this condition. This study was performed as a pilot study 
for planning a treatment of postsurgical anemia after 
gastrectomy. In this study, we found that nearly 40% of pa-
tients with postsurgical anemia achieved a spontaneous 
recovery at 3 months post-surgery, but after then no sig-
nificant recovery was observed until postoperative 12 
months. This may suggest that spontaneous recovery of 
postsurgical anemia can be expected until 3 months 
post-surgery, but proper intervention may be required for 
postsurgical anemia persisting until 3 months post- 
surgery. However, no studies have evaluated proper treat-
ment of postsurgical anemia, such as the efficacy of iron 
supplementation or the best route of iron supplementa-
tion, in patients undergoing gastrectomy. Therefore, prop-
er management for postsurgical anemia needs to be fur-
ther evaluated in further clinical trials.
In the present study, old age, preoperative anemia, se-
verity of anemia (moderate anemia), and total gas-
trectomy were found to be independent factors adversely 
affecting the recovery of postsurgical anemia. This is prob-
ably because elderly patients or patients that undergo to-
tal gastrectomy are more likely to suffer from iron mal-
absorption due to poor oral intake and malnutrition 
[18,19]. Furthermore, patients with preoperative anemia 
possibly have underlying predisposition for the develop-
ment of anemia. Therefore, our study suggests that the 
treatment of postsurgical anemia may require tailored ap-
proaches for these patients, such as an earlier active inter-
vention or intravenous iron supplementation rather than 
oral supplementation. However, this also should be eval-
uated by clinical trials. 
The treatment of postsurgical anemia, especially with 
respect to the efficacy of postoperative iron supplementa-
tion is an issue of long-standing debate [6,7]. Inflamma-
tory response after surgery reduces serum iron and trans-
ferrin and increases serum ferritin, which is indicative of a 
state of functional iron deficiency [20,21], and these phys-
iologic changes may negate the effects of iron supple-
mentation during the postoperative period. In fact, several 
studies have failed to identify a benefit of iron supple-
mentation for the treatment of anemia after non-abdomi-
nal surgeries [9-12]. However, unlike patients undergoing 
orthopedic or cardiac surgery, patients with gastrectomy 
inevitably suffer from poor iron absorption from the gas-
trointestinal tract, and thus, this may adversely affect the 
physiologic recovery from postsurgical anemia [22]. These 
arguments urge that the efficacy of iron supplementation 
during the treatment of postsurgical anemia and the opti-
mal route of iron supplementation needs to be determined Postsurgical anemia after gastrectomy
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in patients undergoing gastrectomy.
It is well known that iron absorption is impaired in a 
multifactorial manner after gastrectomy, and reduced 
food intake, low gastric acidity, rapid gastric emptying, 
and bypass of the upper gastrointestinal tract have all been 
reported to contribute [22]. However, the extent and clin-
ical consequences of iron malabsorption have not been 
fully investigated. In the present study, only six of 88 pa-
tients that did not develop postsurgical anemia developed 
anemia at 12 months postoperatively. This observation 
suggests that iron metabolism is relatively well conserved 
in normal patients despite gastrectomy. Turnberg [23], in a 
experimental study of iron absorption in patient with gas-
trectomy, found that iron absorption was greater in a gas-
trectomy group than in a non-anemic control volunteer 
group. Kimber et al. [24] also concluded that iron mal-
absorption does not necessarily follow gastrectomy. Based 
on these previous studies and our results, we consider that 
the extent of iron malabsorption after gastrectomy is less 
likely to result in impaired hematopoiesis in normal pa-
tients, but that it has a serious impact on the physiological 
compensation required for recovery from postsurgical 
anemia.
Old age, lower BMI, and total gastrectomy were in-
dependent risk factors of developing postsurgical anemia 
after gastrectomy. It may be due to the increased risk of in-
traoperative bleeding or increased vulnerability to hemo-
dilution by perioperative intravenous fluid administra-
tion in the patients with these characteristics. The amount 
of intraoperative bleeding is undoubtedly the most im-
portant factor for developing post-surgical anemia. 
However, accurate measurement of the amount of intra-
operative bleeding is seldom available in many clinical 
settings and sometimes even inconvincible. Therefore, we 
could not include the amount of intraoperative bleeding in 
our study, and thus independent risk factors, like old age, 
lower BMI, and total gastrectomy, are possibly related the 
intraoperative or postoperative bleeding rather than its in-
dependent correlation with the development of post-
surgical anemia. However, under the clinical circum-
stances where accurate measurement of intraoperative or 
postoperative blood loss is not readily available, these fac-
tors can be used to predict the risk of developing the post-
surgical anemia after gastrectomy.
In summary, based on our results, a spontaneous recov-
ery of postsurgical anemia can be expected until 3 months 
post-surgery, but proper intervention may be required for 
postsurgical anemia persisting until postoperative 3 
months. In addition, factors adversely affecting the recov-
ery of postsurgical anemia should be taken into consid-
eration in treatment planning for postsurgical anemia. 
Considering the differences in postoperative physiology 
of iron metabolism in patients undergoing gastrectomy, 
proper treatment of postsurgical anemia, such as the effi-
cacy of the use of iron or the optimum route of iron supple-
mentation, needs to be further evaluated in future clinical 
trials. 
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